Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-677537
Filing Date
2016-08-10
Accepted
2016-08-10 07:41:23
Documents
3
Effectiveness Date
2016-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 d153477ds8.htm S-8 41924
2 EX-5.1 d153477dex51.htm EX-5.1 4479
3 EX-23.1 d153477dex231.htm EX-23.1 1526
  Complete submission text file 0001193125-16-677537.txt   49142
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-213045 | Film No.: 161819981
SIC: 2834 Pharmaceutical Preparations